RSS Items

21 - 30 of 207 results found

6 recent COO-to-CEO transitions

Date
Thursday, September 12, 2024 - 11:07 AM
Description

COO and president were the most common backgrounds for CEOs in 2024, according to a Crist Kolder Associates report.

6 ways physician leaders can curb busywork

Date
Friday, September 13, 2024 - 11:45 AM
Description

An overinterpretation of state and federal regulations often creates unnecessary work for physicians, according to the American Medical Association. 

6-figure media campaign targets NewYork-Presbyterian

Date
Thursday, September 19, 2024 - 11:52 AM
Description

A labor union is launching a six-figure media campaign against New York City-based NewYork-Presbyterian, accusing the health system of charging exorbitant prices, City & State New York reported Sept. 19.

7 health systems selling lab assets

Date
Tuesday, September 17, 2024 - 11:39 AM
Description

Labcorp and Quest Diagnostics are snapping up lab assets from several health systems. Here are seven deals that Becker's has reported in 2024: 

80 hospitals sue HHS over Medicare Advantage Days payment rule

Date
Friday, September 13, 2024 - 9:01 AM
Description

Eighty hospitals are seeking to have the Part C (Medicare Advantage) Days Final rule vacated, alleging that HHS unlawfully reduced disproportionate hospital share payments by an estimated $3 billion to $4 billion over a nine-year period.

83% of physicians are at or above workload capacity

Date
Thursday, September 19, 2024 - 10:30 AM
Description

Eighty-three percent of physicians said they were at full capacity or overextended and overworked in their current practice, a Physicians Foundation survey found.

A look at Oracle Health's new EHR capabilities

Date
Wednesday, September 18, 2024 - 8:58 AM
Description

Oracle Health has unveiled new EHR enhancements aimed at streamlining tasks for healthcare providers, with a focus on improving patient care efficiency and reducing clinician workload.

Agency warns J&J over 340B rebate plan

Date
Wednesday, September 18, 2024 - 9:34 AM
Description

The Health Resources and Services Administration issued a stern warning to Johnson & Johnson on Sept. 17, stating the company's plans to impose 340B rebates on certain drugs are in violation of federal law.